Literature DB >> 11418650

Partially distinct molecular mechanisms mediate inhibitory FcgammaRIIB signaling in resting and activated B cells.

A Brauweiler1, I Tamir, S Marschner, C D Helgason, J C Cambier.   

Abstract

FcgammaRIIB functions as an inhibitory receptor to dampen B cell Ag receptor signals and immune responses. Accumulating evidence indicates that ex vivo B cells require the inositol 5-phosphatase, Src homology domain 2-containing inositol 5-phosphatase (SHIP), for FcgammaRIIB-mediated inhibitory signaling. However, we report here that LPS-activated primary B cells do not require SHIP and thus differ from resting B cells. SHIP-deficient B cell blasts display efficient FcgammaRIIB-dependent inhibition of calcium mobilization as well as Akt and extracellular signal-related protein kinase phosphorylation. Surprisingly, FcgammaRIIB-dependent degradation of phosphatidylinositol 3,4,5-trisphosphate and conversion into phosphatidylinositol 3,4-bisphosphate occur in SHIP-deficient B cell blasts, demonstrating the function of an additional inositol 5-phosphatase. Further analysis reveals that while resting cells express only SHIP, B cell blasts also express the recently described inositol 5-phosphatase, SHIP-2. Finally, data suggest that both SHIP-2 and SHIP can mediate downstream biologic consequences of FcgammaRIIB signaling, including inhibition of the proliferative response.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11418650     DOI: 10.4049/jimmunol.167.1.204

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  FcgammaRIIB signals inhibit BLyS signaling and BCR-mediated BLyS receptor up-regulation.

Authors:  Jenni E Crowley; Jason E Stadanlick; John C Cambier; Michael P Cancro
Journal:  Blood       Date:  2008-09-12       Impact factor: 22.113

2.  The inositol 5-phosphatase SHIP-1 and adaptors Dok-1 and 2 play central roles in CD4-mediated inhibitory signaling.

Authors:  Paul M Waterman; Susanne Marschner; Erin Brandl; John C Cambier
Journal:  Immunol Lett       Date:  2012-02-24       Impact factor: 3.685

Review 3.  The role of toll-like receptors in systemic lupus erythematosus.

Authors:  Adeeb H Rahman; Robert A Eisenberg
Journal:  Springer Semin Immunopathol       Date:  2006-09-19

Review 4.  Signaling mechanisms regulating B-lymphocyte activation and tolerance.

Authors:  Elias Hobeika; Peter J Nielsen; David Medgyesi
Journal:  J Mol Med (Berl)       Date:  2015-01-29       Impact factor: 4.599

Review 5.  Differential roles for the inositol phosphatase SHIP in the regulation of macrophages and lymphocytes.

Authors:  Wai-Hang Leung; Tatyana Tarasenko; Silvia Bolland
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

6.  SH2-containing inositol 5-phosphatases 1 and 2 in blood platelets: their interactions and roles in the control of phosphatidylinositol 3,4,5-trisphosphate levels.

Authors:  Sylvie Giuriato; Xavier Pesesse; Stéphane Bodin; Takehiko Sasaki; Cécile Viala; Evelyne Marion; Joseph Penninger; Stéphane Schurmans; Christophe Erneux; Bernard Payrastre
Journal:  Biochem J       Date:  2003-11-15       Impact factor: 3.857

7.  The regulation of autoreactive B cells during innate immune responses.

Authors:  Barbara J Vilen; Jennifer A Rutan
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

Review 8.  Phosphatase regulation of immunoreceptor signaling in T cells, B cells and mast cells.

Authors:  Yacine Bounab; Andrew Getahun; John C Cambier; Marc Daëron
Journal:  Curr Opin Immunol       Date:  2013-05-15       Impact factor: 7.486

9.  Cultured peripheral blood mast cells from chronic idiopathic urticaria patients spontaneously degranulate upon IgE sensitization: Relationship to expression of Syk and SHIP-2.

Authors:  Sarbjit S Saini; Miya Paterniti; Kavitha Vasagar; Scott P Gibbons; Patricia M Sterba; Becky M Vonakis
Journal:  Clin Immunol       Date:  2009-05-27       Impact factor: 3.969

Review 10.  Regulation of hematopoietic cell function by inhibitory immunoglobulin G receptors and their inositol lipid phosphatase effectors.

Authors:  Carol T Cady; Jeffrey S Rice; Vanessa L Ott; John C Cambier
Journal:  Immunol Rev       Date:  2008-08       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.